Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of [S,S]-reboxetine once daily in fibromyalgia
2007-002381-36Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of reboxetine in fibromyalgia (FM), sponsored by Pfizer. Primary endpoint: Long-term safety and tolerability. Started Sep 2007; status: completed.
02
Drugs
reboxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2007-002381-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002381-36.